Ugonin L inhibits osteoclast formation and promotes osteoclast apoptosis by inhibiting the MAPK and NF-κB pathways - 13/09/23


Abstract |
Bone loss is a major issue for patients with osteoporosis, arthritis, periodontitis, and bone metastasis; however, anti-resorption drugs used to treat bone loss have been linked to a variety of adverse effects. Helminthostachys zeylanica (L.) Hook, belonging to the family Ophioglossaceae, is commonly used in traditional Chinese medicine to treat inflammation and liver problems. In the current study, ugonin L extracted from H. zeylanica was shown to reduce the receptor activator of nuclear factor kappa beta ligand (RANKL)-induced osteoclastogenesis in RAW264.7 cells in a concentration-dependent manner. Ugonin L treatment also inhibited the mRNA expression of osteoclast markers. Ugonin L was also shown to promote cell apoptosis in mature osteoclasts and suppress RANKL-induced ERK, p38, JNK, and NF-κB activation. Taken together, ugonin L appears to be a promising candidate for the development of novel anti-resorption therapies.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Ugonin L attenuated RANKL-stimulated osteoclast formation and osteoclast-specific gene expression. |
• | Ugonin L reduced bone resorption activity and increased cell apoptosis in mature osteoclast. |
• | Ugonin L significantly inhibited RANKL-induced MAPKs and NF-κB pathways. |
Abbreviations : RANKL, ERK, JNK, p38 MAPK, IKK, NF-κB, Acp5, Cts-K, ATP6V1A, MMP9, NFATC1, ALP, BMP-2, COL1A, OPN, Runx2, DAPI, F-actin, GEO, IPA, BSA, RIPA, SDS-PAGE, TBST
Keywords : Ugonin L, Osteoclast, RANKL, Bone resorption, Apoptosis
Plan
Vol 166
Article 115392- octobre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?